MN
MindMed
MNMD·NASDAQNew York NYFounded 201950 employees
Small CapbiotechPublicCNS
Platform: MM120 LSD
Market Cap
$0.5B
All Drugs
2
Clinical Trials
3
Failed / Terminated
0
FDA Approved
1
Stock Price & Catalysts (MNMD)
Loading MNMD stock data...
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Doxatenlimab | MNM-6419 | Phase 2 | 1 | KRASG12C | EoEMCL | ||
| Polacapivasertib | MNM-7855 | Approved | 2 | JAK1 | NBCSU |
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (3)